ATR and neoplasm: Elimusertib (BAY1895344) is a novel ATR inhibitor that produced powerful efficacy as monotherapy and synergistic antitumor activity when combined with radiotherapy, chemotherapy, or other DDR inhibitors in tumor xenograft models [84].